Framework residue 71 is a major determinant of the position and conformation of the second hypervariable region in the VH domains of immunoglobulins.

Analysis of the immunoglobulins of known structure reveals systematic differences in the position and main-chain conformation of the second hypervariable region of the VH domain (H2). We show that the major determinant of the position of H2 is the size of the residue at site 71, a site that is in the conserved framework of the VH domain. It is likely that for about two thirds of the known VH sequences the size of the residue at this site is also a major determinant of the conformation of H2. This effect can override the predisposition of the sequence, as in the case of the H2 loop of J539, which is an exception to the rules relating sequence and conformation of short hairpin loops. Understanding the relationship between the residue at position 71 and the position and conformation of H2 has applications to the prediction and engineering of antigen-binding sites of immunoglobulins.

[1]  J Deisenhofer,et al.  Crystallographic refinement and atomic models of the intact immunoglobulin molecule Kol and its antigen-binding fragment at 3.0 A and 1.0 A resolution. , 1980, Journal of molecular biology.

[2]  G J Williams,et al.  The Protein Data Bank: a computer-based archival file for macromolecular structures. , 1977, Journal of molecular biology.

[3]  C. Milstein,et al.  Reshaping human antibodies: grafting an antilysozyme activity. , 1988, Science.

[4]  D. Davies,et al.  Structural basis of antibody function. , 1983, Annual review of immunology.

[5]  M. L. Mason,et al.  Three‐dimensional structure of a fluorescein–Fab complex crystallized in 2‐methyl‐2,4‐pentanediol , 1989, Proteins.

[6]  R. Poljak,et al.  Three-dimensional structure of an antigen-antibody complex at 2.8 A resolution , 1986, Science.

[7]  M. Lascombe,et al.  Three-dimensional structure of antibodies. , 1988, Annual review of immunology.

[8]  Cyrus Chothia,et al.  Transmission of conformational change in insulin , 1983, Nature.

[9]  A. Lesk,et al.  Canonical structures for the hypervariable regions of immunoglobulins. , 1987, Journal of molecular biology.

[10]  B. L. Sibanda,et al.  β-Hairpin families in globular proteins , 1985, Nature.

[11]  Y. Satow,et al.  Phosphocholine binding immunoglobulin Fab McPC603. An X-ray diffraction study at 2.7 A. , 1985, Journal of molecular biology.

[12]  C. Venkatachalam Stereochemical criteria for polypeptides and proteins. V. Conformation of a system of three linked peptide units , 1968, Biopolymers.

[13]  T. T. Wu,et al.  AN ANALYSIS OF THE SEQUENCES OF THE VARIABLE REGIONS OF BENCE JONES PROTEINS AND MYELOMA LIGHT CHAINS AND THEIR IMPLICATIONS FOR ANTIBODY COMPLEMENTARITY , 1970, The Journal of experimental medicine.

[14]  E. Kabat,et al.  Sequences of proteins of immunological interest , 1991 .

[15]  B. L. Sibanda,et al.  Conformation of beta-hairpins in protein structures. A systematic classification with applications to modelling by homology, electron density fitting and protein engineering. , 1989, Journal of molecular biology.

[16]  T. Bhat,et al.  The galactan‐binding immunoglobulin Fab J539: An x‐ray diffraction study at 2.6‐Å resolution , 1986, Proteins.

[17]  M Levitt,et al.  The predicted structure of immunoglobulin D1.3 and its comparison with the crystal structure , 1986, Science.

[18]  A M Lesk,et al.  Evolution of proteins formed by beta-sheets. II. The core of the immunoglobulin domains. , 1982, Journal of molecular biology.

[19]  L M Amzel,et al.  Preliminary refinement and structural analysis of the Fab fragment from human immunoglobulin new at 2.0 A resolution. , 1981, The Journal of biological chemistry.

[20]  G. M. Griffiths,et al.  Molecular events during maturation of the immune response to oxazolone , 1985, Nature.

[21]  G. G. Stokes "J." , 1890, The New Yale Book of Quotations.

[22]  J. N. Varghese,et al.  Three-dimensional structure of a complex of antibody with influenza virus neuraminidase , 1987, Nature.

[23]  P. T. Jones,et al.  Replacing the complementarity-determining regions in a human antibody with those from a mouse , 1986, Nature.

[24]  R J Fletterick,et al.  Interactive program for visualization and modelling of proteins, nucleic acids and small molecules , 1986 .

[25]  Lutz Riechmann,et al.  Reshaping human antibodies for therapy , 1988, Nature.